Allyx Therapeutics logo — Protecting Synapses and Reversing Neurodegeneration

Allyx Therapeutics

Protecting Synapses and Reversing Neurodegeneration

Founded 2018 United States New Haven, United States 5 employees Venture round Total: $10.12M Biotechnology, Health Care +1

General Information

Company Name Allyx Therapeutics
Founded Year 2018
Location United States New Haven, United States
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Allyx Therapeutics. To contact Allyx Therapeutics, visit allyxthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Allyx Therapeutics compare?

A PDF of Allyx Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Allyx Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Allyx Therapeutics

Allyx Therapeutics is a clinical stage biotechnology company founded in 2018 with the mission to develop disease modifying therapies for Alzheimer's and Parkinson's disease. The company's slogan, "Protecting Synapses and Reversing Neurodegeneration," reflects its focus on targeting the underlying cause of synapse dysfunction and loss. Based in the United States, Allyx Therapeutics recently secured a significant $2.31M Venture Round investment on 09 February 2023. With its dedication to addressing critical unmet needs in neurodegenerative diseases, Allyx Therapeutics is poised to make a significant impact in the Biotechnology, Health Care, and Life Sciences industries.

Business keywords: Allyx Therapeutics, clinical stage, neurodegeneration, Alzheimer's disease, Parkinson's disease, disease modifying therapies, synapse dysfunction, small molecule, oral drug, cognition preservation, neurological disorders, clinical trials, drug development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.31M -
09 Feb 2023
Series A $7.58M 5
Life Science Angels, Elm Street Ventures +3
01 Jun 2021
Venture Round Undisclosed 1
Life Science Angels
01 Jan 2021
Convertible Note $230.00K 1
Connecticut Innovations
03 Apr 2019

Allyx Therapeutics Alternatives & Competitors

View All Alternatives
Allyx Therapeutics vs
Asceneuron SA
Asceneuron SA Switzerland

Targeting the root cause of neurodegeneration

Series C
20 employees
Biotechnology, Health Care
Allyx Therapeutics vs
Libra Therapeutics
Libra Therapeutics United States

Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease

Series A
4 employees
Biotechnology, Health Care
Allyx Therapeutics vs

Pioneering advanced treatments for Alzheimer’s and Parkinson’s diseases since 2013.

Grant
6 employees
Biotechnology, Health Care

FAQ About Allyx Therapeutics

Protecting Synapses and Reversing Neurodegeneration
Allyx Therapeutics was founded in 2018.
Allyx Therapeutics is headquartered in New Haven, United States.
Allyx Therapeutics operates in Biotechnology, Health Care and Life Sciences. Its work centres on Allyx Therapeutics, clinical stage, neurodegeneration and Alzheimer's disease.
Allyx Therapeutics has approximately 5 employees.
Allyx Therapeutics has completed 4 funding rounds, raising a total of $10.12M. The latest funding stage is Venture round.
Top alternatives and competitors to Allyx Therapeutics include Asceneuron SA, Libra Therapeutics, Gismo Therapeutics Inc., Wren Therapeutics, XWPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Allyx Therapeutics and Asceneuron SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Allyx Therapeutics, https://bouncewatch.com/company/allyx-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes